MOUNTAIN VIEW, CA / ACCESS Newswire / May 13, 2025 / AbTherx, Inc., a biotechnology company with innovative transgenic technologies that simplify and accelerate antibody discovery, today announced a ...

Losses at Advanced Cell Technology (ACT) of Marlborough deepened in its first quarter, as the cost of clinical trials for its macular degeneration treatments rose, the company said. Advanced Cell ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Worcester biotech Advanced Cell Technology Inc. and Korean ...

As the international effort reaches a ‘critical mass’ of achievements, Nature highlights seven tools that are poised to enable the next set of discoveries. Single-cell technologies have shattered the ...

Advanced Cell Technology Inc. wins $25 million commitment from investment firm Socius Capital Group. Advanced Cell Technology Inc. (OTC:ACTC) secured a $25 million investment to support clinical ...